The role of the CDX2 gene in colorectal cancer
Author Information
Author(s): Sivagnanasundaram S, Islam I, Talbot I, Drummond F, Walters J R F, Edwards Y H
Primary Institution: MRC Human Biochemical Genetics Unit, Biology Department, University College London
Hypothesis
Is the CDX2 gene implicated in the pathogenesis of sporadic colorectal cancer?
Conclusion
The study found that loss of CDX2 contributes to the progression of some sporadic colorectal cancer tumors.
Supporting Evidence
- Six polymorphisms were identified in the study.
- Two rare variants were found, one of which was only in a CRC case.
- Loss of heterozygosity was observed in 3 out of 28 CRC cases.
- A possible association between haplotypes and tumor progression was suggested.
Takeaway
Scientists looked at a gene called CDX2 to see if it plays a role in some types of colon cancer, and they found that losing this gene might help the cancer grow.
Methodology
The study involved searching for DNA polymorphisms and rare variants in CRC tumors and analyzing the expression of CDX2 alleles.
Limitations
Further analysis is required to draw definitive conclusions about CDX2 mutations and their role in CRC.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website